Efecto neuroprotector de los cannabinoides en las enfermedades neurodegenerativas

Objectives. It is analysed the actual situation of the investigations related to cannabinoids substances,as well as their interaction with the organism, classification, therapeutics effects and their use in neurodegenerativediseases. Methods. This study is based on the review of multiples scientific articles directly related with the cannabinoidessubstance and its synthetic derivates, with a special attention on the way the organism interactsand the effects the substances cause in it. Specifically, the study will get deep into the neuroantiinflammatoryand analgesic effects of these substances, related with the neuroprotector effect in neurodegenerativediseases such as Alzheimer, Parkinson, Multiple Sclerosis and Amyotrophic Lateral Sclerosis. Results. From thousands years, the Cannabis Sativa has been used by multiples cultures with differentpurposes such as joy, textile, analgesics etc. But is not till ends of the XX century when there are diversescientific studies related with the Cannabis encouraged. The plant has 400 components, 60 of them belongto the cannabinoides group. The main ones are cannabinol, cannabidiol and tetrahidrocannabinol.With the discoverment of the cannabinoids substances, its derivates, and the receptors which interact with them, it is increased the therapeutic possibilities and remarking the neuroprotective effect which these substances contain. Conclusions. It has been demostraded the huge potential of the cannabinoids as therapeutic substances apart from its analgesic and antiemetic uses, that is, neurodegenaritve diseases in which they can not only decrease its symptons but stop disease process. Another possible application could be in the oncologic area, being particularly intense the investigation´s activity realised the last 15 years.